| Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape BN Bidwell, CY Slaney, NP Withana, S Forster, Y Cao, S Loi, D Andrews, ... Nature medicine 18 (8), 1224-1231, 2012 | 516 | 2012 |
| Cathepsin B inhibition limits bone metastasis in breast cancer NP Withana, G Blum, M Sameni, C Slaney, A Anbalagan, MB Olive, ... Cancer research 72 (5), 1199-1209, 2012 | 223 | 2012 |
| Improved quenched fluorescent probe for imaging of cysteine cathepsin activity M Verdoes, K Oresic Bender, E Segal, WA van der Linden, S Syed, ... Journal of the American Chemical Society 135 (39), 14726-14730, 2013 | 206 | 2013 |
| Functional imaging of legumain in cancer using a new quenched activity-based probe LE Edgington, M Verdoes, A Ortega, NP Withana, J Lee, S Syed, ... Journal of the American Chemical Society 135 (1), 174-182, 2013 | 163 | 2013 |
| Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery LO Ofori, NP Withana, TR Prestwood, M Verdoes, JJ Brady, MM Winslow, ... ACS chemical biology 10 (9), 1977-1988, 2015 | 113 | 2015 |
| Non-invasive imaging of idiopathic pulmonary fibrosis using cathepsin protease probes NP Withana, X Ma, HM McGuire, M Verdoes, WA van der Linden, LO Ofori, ... Scientific reports 6 (1), 19755, 2016 | 99 | 2016 |
| Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins. BM Segal E, Prestwood TR, van der Linden WA, Carmi Y, Bhattacharya N ... Chem Biol. 22 (1), 148-58, 2015 | 77 | 2015 |
| Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes NP Withana, M Garland, M Verdoes, LO Ofori, E Segal, M Bogyo Nature protocols 11 (1), 184-191, 2016 | 57 | 2016 |
| Dual-modality activity-based probes as molecular imaging agents for vascular inflammation NP Withana, T Saito, X Ma, M Garland, C Liu, H Kosuge, M Amsallem, ... Journal of Nuclear Medicine 57 (10), 1583-1590, 2016 | 47 | 2016 |
| Legumain is activated in macrophages during pancreatitis LE Edgington-Mitchell, T Wartmann, AK Fleming, V Gocheva, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 311 (3 …, 2016 | 33 | 2016 |
| Transcriptome analysis reveals season‐specific rbcS gene expression profiles in diploid perennial ryegrass (Lolium perenne L.) P Sathish, N Withana, M Biswas, C Bryant, K Templeton, M Al‐Wahb, ... Plant Biotechnology Journal 5 (1), 146-161, 2007 | 27 | 2007 |
| Telomere length in lymphoblast cell lines derived from clinically radiosensitive cancer patients CN Sprung, DSP Davey, NP Withana, LV Distel, MJ McKay Cancer Biology & Therapy 7 (5), 638-644, 2008 | 18 | 2008 |
| Control of plant gene expression S Puthigae, JR Phillips, NP Withana, CJ Smith-Espinoza, CJ Bryant, ... US Patent App. 12/594,585, 2010 | 6 | 2010 |
| Lymphoid and fibroblastic cell lineages from radiosensitive cancer patients: Molecular analysis of DNA double strand break repair by major non‐homologous end‐joining sub‐pathways MJ McKay, N Withana, DS Davey, D Bishop, M Chao, CN Sprung Asia‐Pacific Journal of Clinical Oncology 7 (1), 17-26, 2011 | 1 | 2011 |
| Protease-activated contrast agents for in vivo imaging MS Bogyo, M Verdoes, L Ofori, NP Withana US Patent App. 18/489,653, 2024 | | 2024 |
| Protease-activated contrast agents for in vivo imaging MS Bogyo, M Verdoes, L Ofori, NP Withana US Patent App. 18/053,682, 2024 | | 2024 |
| Protease-activated contrast agents for in vivo imaging MS Bogyo, M Verdoes, L Ofori, NP Withana US Patent 11,828,752, 2023 | | 2023 |
| CONTRAST AGENTS ACTIVATED BY A PROTEASE FOR IN VIVO IMAGING MS Bogyo, M VERDOES, L OFORI, NP WITHANA | | 2021 |
| Protease-activated contrast agents for in vivo imaging MS Bogyo, M Verdoes, L Ofori, NP Withana US Patent App. 16/792,142, 2020 | | 2020 |
| Protease-activated contrast agents for in vivo imaging MS Bogyo, M Verdoes, L Ofori, NP Withana US Patent 10,570,173, 2020 | | 2020 |
